featured
Biomarkers in Bladder Cancer: Delivery of Precision Medicine
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Solomon DA, Kim JS, Bondaruk J, et al. Frequent truncating mutations of STAG2 in bladder cancer. Nat Genet. 2013;45(12):1428-1430.
- Guo G, Sun X, Chen C, et al. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat Genet. 2013;45(12):1459-1463.
- Balbás-Martínez C, Sagrera A, Carrillo-de-Santa-Pau E, et al. Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy. Nat Genet. 2013;45(12):1464-1469.
- Esrig D, Elmajian D, Groshen S, et al. Accumulation of Nuclear p53 and Tumor Progression in Bladder Cancer. N Engl J Med. 1994;331(19):1259-1264.
- Dancik GM, Theodorescu D. Robust Prognostic Gene Expression Signatures in Bladder Cancer and Lung Adenocarcinoma Depend on Cell Cycle Related Genes. PLoS ONE. 2014;9(1):e85249.